Risultati della ricerca - Yu-Zhou Gui

  • Mostra 1 - 4 risultati su 4
Raffina i risultati
  1. 1
    Safety, tolerability, pharmacokinetics, and pharmacodynamics of a soluble guanylate cyclase stimulator, HEC95468, in healthy volunteers: a randomized, double-blinded, placebo-controlled phase 1 trial

    Safety, tolerability, pharmacokinetics, and pharmacodynamics of a soluble guanylate cyclase stimulator, HEC95468, in healthy volunteers: a randomized, double-blinded, placebo-contr... di Yu-zhou Gui, Yu-zhou Gui, Wei Wang, Wei Wang, Qing-qing Wu, Qing-qing Wu, Qi-chen Ding, Qi-chen Ding, Hong-jie Qian, Hong-jie Qian, Qiu-bei Lu, Ying-jun Zhang, Yu-lei Zhuang, Li Deng, Ying-lin Zuo, Lin Luo, Jing-ying Jia, Jing-ying Jia

    Pubblicazione 2024-06-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Sodium tanshinone IIA silate inhibits high glucose-induced vascular smooth muscle cell proliferation and migration through activation of AMP-activated protein kinase.

    Sodium tanshinone IIA silate inhibits high glucose-induced vascular smooth muscle cell proliferation and migration through activation of AMP-activated protein kinase. di Wen-yu Wu, Hong Yan, Xin-bo Wang, Yu-zhou Gui, Fei Gao, Xi-lan Tang, Yin-lin Qin, Mei Su, Tao Chen, Yi-ping Wang

    Pubblicazione 2014-01-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos)Research in context

    Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel cont... di Yi Fang, Jing-Xin Li, Davone Duangdany, Yang Li, Xi-Lin Guo, Chanthala Phamisith, Bo Yu, Ming-Yun Shen, Bin Luo, Yu-Zhu Wang, Si-Jun Liu, Fan-Fan Zhao, Cong-Cong Xu, Xu-Hui Qiu, Rong Yan, Yu-Zhou Gui, Rong-Juan Pei, Jie Wang, Haifa Shen, Wu-Xiang Guan, Hang-Wen Li, Mayfong Mayxay

    Pubblicazione 2024-01-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trialResearch in context

    Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phas... di Yu-Zhou Gui, Xue-Ning Li, Jing-Xin Li, Ming-Yun Shen, Mei-Wei Zhang, Ye Cao, Hong-Rong Xu, Hui Li, Jie Cheng, Liang Pan, Ying-Lei Yi, Li-Yu Liang, Cheng-Yin Yu, Gang-Yi Liu, Chen Yu, Bi-Jie Hu, Feng-Cai Zhu, Fei Liang, Haifa Shen, Jing-Ying Jia, Hang-Wen Li, Jian Zhou, Jia Fan

    Pubblicazione 2023-05-01
    Testo
    Articolo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: